Select for export Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221127304 PubMed 36314881 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-10-30 Jones GM. Europe PMC Published psilocybin DepressionObservational StudyDrug Interactions Observational Study More
Select for export To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000597 PubMed 36048112 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2022-08-31 Christensen JA, Fipps DC, Bostwick JM. Europe PMC Published psilocybin AddictionBrain ImagingReview Article Review Article More
Select for export The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06187-5 PubMed 35939083 Copy citation Copy BibTeX Psychopharmacology 2022-08-07 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L Europe PMC Published psilocybin DepressionEmotional ProcessingClinical Trial Randomized Controlled Trial More
Select for export Med Check: Psilocybin for OCD, Nuplazid Vote, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.08.8.2 Copy citation Copy BibTeX Psychiatric News 2022-07-31 Terri D’Arrigo OpenAlex Published psilocybin DepressionOCDHeadache / Migraine Clinical Trial More
Select for export Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852922000888 PubMed 35811423 Copy citation Copy BibTeX Unknown journal 2022-07-10 Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Review Article More
Select for export Natural language signatures of psilocybin microdosing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06170-0 PubMed 35676541 Copy citation Copy BibTeX Psychopharmacology 2022-06-08 Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M Europe PMC Published psilocybin MicrodosingWellbeingCreativity Other More
Select for export Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.06.6.30 Copy citation Copy BibTeX Psychiatric News 2022-05-22 Richard Karel OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.788155 PubMed 35431912 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-30 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J Europe PMC Published psilocybin DepressionEmotional ProcessingMystical Experience Randomized Controlled Trial More
Select for export Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.841648 PubMed 35355714 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-08 McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S Europe PMC Published psilocybin Mystical ExperienceHealthy Volunteers Qualitative Study More
Select for export Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06092-x PubMed 35233648 Copy citation Copy BibTeX Unknown journal 2022-03-01 Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Europe PMC Published psilocybin DepressionAddictionPharmacology Animal Study More
Select for export Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-021-06020-5 PubMed 35234983 Copy citation Copy BibTeX Psychopharmacology 2022-03-01 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N Europe PMC Published psilocybinpsilocin DepressionReceptor Pharmacology Other More
Select for export The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073758 PubMed 35253518 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-02-28 Wolff M, Mertens LJ, Walter M, Enge S, Evens R. Europe PMC Published psilocybin Mechanism of ActionPsychological FlexibilityObservational Study Observational Study More
Select for export Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01297-2 PubMed 35217796 Copy citation Copy BibTeX Neuropsychopharmacology 2022-02-24 Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P Europe PMC Published psilocybin AnxietyPharmacologyHealthy Volunteers Clinical Trial More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06066-z PubMed 35076721 Copy citation Copy BibTeX Psychopharmacology 2022-01-24 Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y Europe PMC Published psilocybin Clinical TrialHealthy Volunteers Clinical Trial More
Select for export Analysis of recreational psychedelic substance use experiences classified by substance. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06062-3 PubMed 35031816 Copy citation Copy BibTeX Psychopharmacology 2022-01-14 Hase A, Erdmann M, Limbach V, Hasler G. Europe PMC Published psilocybin AddictionBiomarkersEmotional Processing Clinical Trial More
Select for export MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211058923 PubMed 34983249 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin Observational StudyAdolescentsSafety Observational Study More
Select for export Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211066714 PubMed 34983261 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-04 Jones GM, Nock MK. Europe PMC Published psilocybin DepressionAddictionChronic Pain Observational Study More
